Product name:Dorzolamide
Product description:Dorzolamide (trade name Trusopt) is a carbonic anhydrase inhibitor. It is an anti-glaucoma agent and topically applied in the form of eye drops. This drug, developed by Merck, was the first drug in human therapy (market introduction 1995) which resulted from structure-based drug design. Dorzolamide hydrochloride is used to lower increased intraocular pressure in open-angle glaucoma and ocular hypertension.The combination of dorzolamide with timolol is marketed under the trade name Cosopt.
CAS No.:120279-96-1
Synonyms: (2R,4R)-2-Ethylamino-4-methyl-5,5-dioxo-5,7-dithiabicyclo[4.3.0]nona-8,10-diene-8-sulfonamide
Molecular formula: C10H16N2O4S3
Molecular weight: 324.44